Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Jun 02, 2014 12:29pm
246 Views
Post# 22621289

RE:RE:Any long term investors?

RE:RE:Any long term investors?
naimarantz wrote:
 I will answer questions briefly which took about 1 hour to check into. Hopefully this helps.

1) TLT has gone from initial invitro testing of cancers in 2010 to ...............

Starting testing on small animals on 11/ 2010 
Success on 1 small animal on 12 / 2012 
Discovering PDCs can prevent recurrence of cancer in 03 /2012
Bladder cancer being selected as first clinical trial target in 07/ 2012
PDCs being approved for live animal bladder cancer model in 03/2013
Discovering previous colon cancer mice were alive 20 months after treatment on 10/ 2013
The latest blockbuster news where anti cancer memory response was proven even after mice were reinjected with 350,000 cancer cells. 05/ 2014

It appears things are a lot different now than the initial invetro stages in 2010. 

2) Company is carrying on and results are coming in.

3) The technology is refined enough to be going to human trials in about 6 months.....


Great summary, thank you. A lot of progress and a lot to look forward to.

Bullboard Posts